Table 4. Treatment given for cervical cancer by race, stratified by stage of disease at diagnosis.
| Early Stage Disease (Stage 1A, 1A1, 1A2, 1B, 1B1, 1B2, 1NOS) | ||||
| Non-Hispanic White |
Non-Hispanic Black |
Hispanic | Other | |
| (n = 4,332) | (n = 844) | (n = 1,869) | (n = 723) | |
| Radiation | ||||
| EBRT + Brachytherapy | 482 (11%) | 109 (13%) | 167 (9%) | 59 (8%) |
| EBRT alone | 468 (11%) | 128 (15%) | 238 (13%) | 86 (12%) |
| Brachy alone | 75 (2%) | 41 (5%) | 47 (3%) | 14 (2%) |
| Radiation NOS | 3 (0.1%) | 3 (0.4%) | 10 (0.5%) | 1 (0.1%) |
| No radiation | 3,228 (75%) | 543 (64%) | 1,388 (74%) | 552 (76%) |
| Unknown/refused | 76 (2%) | 20 (2%) | 19 (1%) | 11 (2%) |
| Surgical Management | ||||
| No surgery | 378 (9%) | 142 (17%) | 231 (12%) | 57 (8%) |
| Radical hysterectomy | 715 (17%) | 96 (11%) | 294 (16%) | 144 (20%) |
| Local destruction | 726 (17%) | 154 (18%) | 281 (15%) | 125 (17%) |
| TAH | 592 (14%) | 95 (11%) | 276 (15%) | 75 (10%) |
| TAH-BSO | 943 (22%) | 199 (24%) | 417 (22%) | 164 (23%) |
| Modified radical and/or extended hysterectomy | 714 (16%) | 105 (12%) | 288 (15%) | 121 (17%) |
| Hysterectomy NOS | 235 (5%) | 48 (6%) | 75 (4%) | 34 (5%) |
| Pelvic exenteration | 4 (0.1%) | 0 (0%) | 1 (0.1%) | 1 (0.1%) |
| Surgery NOS | 9 (0.2%) | 1 (0.1%) | 1 (0.1%) | 1 (0.1%) |
| Surgery Unknown | 5 (0.2%) | 1 (0.1%) | 0 (0%) | 0 (0%) |
| Other | 11 (0.3) | 3 (0.4%) | 5 (0.3%) | 1 (0.1%) |
| Late Stage Disease (Stage 2A, 2B, 2NOS, 3A, 3B, 3NOS) | ||||
| Non-Hispanic White |
Non-Hispanic Black |
Hispanic | Other | |
| (n = 2,494) | (n = 828) | (n = 1,213) | (n = 526) | |
| Radiation | ||||
| EBRT + Brachytherapy | 1,152 (46%) | 304 (37%) | 487 (40%) | 228 (43%) |
| EBRT alone | 912 (37%) | 337 (41%) | 489 (40%) | 191 (36%) |
| Brachy alone | 200 (8%) | 83 (10%) | 111 (9%) | 44 (8%) |
| Radiation NOS | 13 (0.5%) | 8 (1%) | 11 (1%) | 5 (1%) |
| No radiation | 170 (7%) | 70 (8%) | 95 (8%) | 48 (9%) |
| Unknown/refused | 47 (2%) | 26 (3%) | 20 (2%) | 10 (2%) |
| Surgical Management | ||||
| No surgery | 1,575 (63%) | 621 (75%) | 798 (66%) | 331 (63%) |
| Radical hysterectomy | 199 (8%) | 25 (3%) | 101 (8%) | 54 (10%) |
| Local destruction | 213 (9%) | 85 (10%) | 92 (8%) | 35 (7%) |
| TAH | 33 (1%) | 10 (1%) | 29 (2%) | 6 (1%) |
| TAH-BSO | 206 (8%) | 37 (4%) | 85 (7%) | 54 (11%) |
| Modified radical and/or extended hysterectomy | 176 (7%) | 29 (4%) | 67 (6%) | 30 (6%) |
| Hysterectomy NOS | 60 (2%) | 15 (2%) | 27 (2%) | 10 (2%) |
| Pelvic exerteration | 10 (0.4%) | 1 (0.1%) | 3 (0.3%) | 1 (0.2%) |
| Surgery NOS | 14 (0.6%) | 3 (0.4%) | 10 (0.8%) | 5 (1%) |
| Surgery Unknown | 5 (0.2%) | 2 (0.2%) | 0 (0%) | 0 (0%) |
| Other | 3 (0.1%) | 0 (0%) | 1 (0.1%) | 0 (0%) |